Bioequivalence Study Of Verapamil

Completed · Phase 1

Conditions studied: Healthy Volunteers

In brief

The purpose of this study is to demonstrate bioequivalence of single doses of two verapamil formulations

Key facts

Study ID

NCT00668967

Run by

Pfizer

People needed

79

Starts

2008-02-01

Expected to finish

2008-07-01

Last updated by the study team

2009-07-08

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male and/or female subjects
• Mass Index (BMI) of approximately 18 to 30 kg/m2

You may not qualify if…

• Any condition possibly affecting drug absorption
• A positive urine drug screen

Where it is running

• Pfizer Investigational Site — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.